1. Home
  2. RM vs BWAY Comparison

RM vs BWAY Comparison

Compare RM & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regional Management Corp.

RM

Regional Management Corp.

HOLD

Current Price

$39.62

Market Cap

356.4M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.73

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RM
BWAY
Founded
1987
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
356.4M
337.9M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
RM
BWAY
Price
$39.62
$16.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$30.00
$23.50
AVG Volume (30 Days)
59.1K
59.5K
Earning Date
02-04-2026
11-11-2025
Dividend Yield
2.99%
N/A
EPS Growth
71.26
213.09
EPS
4.13
0.13
Revenue
$610,145,000.00
$49,094,000.00
Revenue This Year
$16.34
$330.76
Revenue Next Year
$7.05
$22.24
P/E Ratio
$9.70
$52.44
Revenue Growth
9.60
27.08
52 Week Low
$25.41
$7.84
52 Week High
$46.00
$18.18

Technical Indicators

Market Signals
Indicator
RM
BWAY
Relative Strength Index (RSI) 58.29 55.03
Support Level $35.99 $16.75
Resistance Level $40.40 $18.18
Average True Range (ATR) 1.40 0.74
MACD 0.39 0.05
Stochastic Oscillator 83.03 70.49

Price Performance

Historical Comparison
RM
BWAY

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: